Marc van der Waude, Marc van der Waude, Nov 01, 2009
The purpose of this contribution is to explore the status types that settlements and reverse payments could have under Article 81 EC. It seeks to identify the elements of the legal tests which could possibly be applied to assess the legality of such settlements and, in particular, those providing for a value transfer from the originator to the generic firm. This will be done as follows: Section 2 summarizes the main findings of the Final Report on settlement agreements; Section 3 makes an inventory of relatively old case law that dealt with comparable issues or those related to patent settlement agreements; and Section 4 makes an attempt to distill a legal test from the two previous sections for the assessment of patent settlement agreements between originator and generic firms under EC competition law.
Featured News
EU Raises Antitrust Objections to MMG’s Anglo American Nickel Deal
Sep 16, 2026 by
CPI
DOJ Backs Bond Requirement in Paramount-Warner Bros. Antitrust Fight
Sep 16, 2026 by
CPI
Crowell & Moring Adds DOJ, FTC Veterans to Antitrust Practice
Sep 16, 2026 by
CPI
EU Weighs Antitrust Flexibility for AI Safety Cooperation
Sep 16, 2026 by
CPI
OpenAI Challenges Secrecy of Musk Companies’ Apple Deal
Sep 16, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Computational Antitrust
Sep 16, 2026 by
CPI
The Next Five Years of Computational Antitrust
Sep 16, 2026 by
Thibault Schrepel
When Two AI Agents Talk: A Gap in Detection Capabilities
Sep 16, 2026 by
Alba Ribera Martinez
When Innovation Competition Has No Product Yet: Making General Innovation Competition Operational
Sep 16, 2026 by
Mariateresa Maggiolino
Computational Antitrust for Complex Adaptive Markets
Sep 16, 2026 by
Filip Lubinski